Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hwang, Hyerim
NCT05130463: Esgliteo Post Marketing Surveillance (PMS) in Korean Patients With Type 2 Diabetes Mellitus	Completed	N/A	1053	RoW	empagliflozin/linagliptin, Esgliteo®	Boehringer Ingelheim	Diabetes Mellitus, Type 2	04/24	07/24
NCT05236673: Jardiance® Post Marketing Surveillance (PMS) in Korean Patients With Chronic Heart Failure	Active, not recruiting	N/A	600	RoW	JARDIANCE®, empagliflozin	Boehringer Ingelheim	Heart Failure	05/25	08/25